Status:
COMPLETED
Influence of Patient Choice of Intrathecal Morphine on Post-cesarean Delivery Pain.
Lead Sponsor:
Stanford University
Conditions:
Pain
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
This is a randomized controlled study that will place patients into a "choice" and a "no choice" group. The choice group will be able to choose between receiving 100 mcg or 200 mcg intrathecal morphin...
Detailed Description
This randomised controlled study will include pre-operative screening with a 2 simple questionnaires and the patient will be randomised into a "choice" and "no choice" groups. The group with the choi...
Eligibility Criteria
Inclusion
- Women age 18-50 with singleton, term gestation fetuses and scheduled for their 1st, 2nd, or 3rd elective CS (not in labor) will be included.
Exclusion
- Patient refusal.
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2013
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01425762
Start Date
August 1 2011
End Date
July 1 2013
Last Update
November 13 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305